Michael Weintraub Sells 861 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) Director Michael Weintraub sold 861 shares of the stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $25.26, for a total transaction of $21,748.86. Following the completion of the transaction, the director now owns 242,827 shares of the company’s stock, valued at $6,133,810.02. This represents a 0.35 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Michael Weintraub also recently made the following trade(s):

• On Friday, December 13th, Michael Weintraub sold 20,565 shares of Phreesia stock. The stock was sold at an average price of $25.04, for a total transaction of $514,947.60.
• On Monday, December 2nd, Michael Weintraub sold 15,152 shares of Phreesia stock. The shares were sold at an average price of $21.01, for a total transaction of $318,343.52.

Phreesia Price Performance

NYSE PHR opened at $24.01 on Thursday. The company has a current ratio of 1.74, a quick ratio of 1.77 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $29.16. The company has a market cap of $1.40 billion, a PE ratio of -16.33 and a beta of 0.98. The stock’s 50-day moving average price is $20.66 and its two-hundred day moving average price is $21.90.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. During the same quarter in the previous year, the business earned ($0.58) earnings per share. The firm’s revenue was up 16.6% compared to the same quarter last year. On average, analysts predict that Phreesia, Inc. will post -1.16 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Robert W. Baird cut their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th. Royal Bank of Canada restated a “sector perform” rating and issued a $23.00 price objective on shares of Phreesia in a report on Friday, September 27th. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 target price on shares of Phreesia in a research note on Tuesday, December 10th. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Finally, Truist Financial upped their price target on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, Phreesia currently has an average rating of “Moderate Buy” and a consensus target price of $29.33.

Institutional Trading of Phreesia

A number of hedge funds have recently modified their holdings of PHR. Bank of New York Mellon Corp grew its holdings in shares of Phreesia by 8.4% during the second quarter. Bank of New York Mellon Corp now owns 214,430 shares of the company’s stock valued at $4,546,000 after buying an additional 16,614 shares in the last quarter. Peregrine Capital Management LLC boosted its position in Phreesia by 11.3% during the 2nd quarter. Peregrine Capital Management LLC now owns 354,607 shares of the company’s stock worth $7,518,000 after acquiring an additional 36,047 shares during the period. nVerses Capital LLC boosted its position in Phreesia by 76.5% during the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock worth $64,000 after acquiring an additional 1,300 shares during the period. Rhumbline Advisers grew its stake in Phreesia by 1.0% during the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock valued at $1,741,000 after acquiring an additional 853 shares in the last quarter. Finally, Arcadia Investment Management Corp MI increased its holdings in shares of Phreesia by 13.9% in the 2nd quarter. Arcadia Investment Management Corp MI now owns 88,625 shares of the company’s stock valued at $1,879,000 after purchasing an additional 10,800 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.